Euro Parliament's rejection of software patent Directive finds large & small firms on opposing sides
This article was originally published in Clinica
The European Parliament has thrown out the European Commission's 2002 proposed software patents Directive in a decision that will have repercussions on medical device manufacturers whose products rely on software.
You may also be interested in...
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.